Gatifloxacin hydrobride as quinolone compound and its prepn and application as antibacterial agent

A technology of gatifloxacin and quinolones, applied in antibacterial drugs, organic chemistry, pharmaceutical formulations, etc., can solve problems such as unstable light exposure, easy yellowing of aqueous solutions, and achieve good product stability, good water solubility, Low irritant effect on human body

Inactive Publication Date: 2004-11-24
海南康福中正发展有限公司 +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the salt forms are methanesulfonate, hydrochloride, and lactate, but the above salt f

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Gatifloxacin hydrobride as quinolone compound and its prepn and application as antibacterial agent
  • Gatifloxacin hydrobride as quinolone compound and its prepn and application as antibacterial agent
  • Gatifloxacin hydrobride as quinolone compound and its prepn and application as antibacterial agent

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] Get 30ml of ethanol, 10 grams (0.027mol) of gatifloxacin, in a 250ml there-necked flask, stir and react at 45°C for 0.5 hour, add 6.5g (40%) (0.032mol) of hydrobromic acid, react at 50°C for 2 hours, drop to room temperature, suction filtered, washed with 10 ml of absolute ethanol × 2, and vacuum-dried to obtain 11 g of gatifloxacin hydrobromide.

Embodiment 2

[0019] Take 20ml of water, 10g (0.027mol) of gatifloxacin, in a 250ml there-necked flask, stir and react at 50°C for 0.5 hours, add 5.5g (40%) (0.027mol) of hydrobromic acid, react at 50°C for 2 hours, add acetone 100ml, cooled to room temperature, suction filtered, washed with 10ml of 90% acetone aqueous solution × 2, and vacuum-dried to obtain 10 grams of gatifloxacin hydrobromide.

Embodiment 3

[0021] 8.2 g (40%) (0.0405 mol) of hydrobromic acid, 30 ml of ethanol, and 10 g (0.027 mol) of gatifloxacin.

[0022] Get ethanol 30ml, gatifloxacin 10 grams (0.027mol), in 250ml there-necked bottle, 45 ℃ of stirring reaction 0.5 hour, add hydrobromic acid 8.2 gram (40%) (0.0405mol), 50 ℃ of reaction 2 hours, drop to room temperature, suction filtered, washed with 10 ml of absolute ethanol × 2, and vacuum-dried to obtain 10.8 g of gatifloxacin hydrobromide.

[0023] Tests have shown that the aqueous solution of the above-mentioned quinolone gatifloxacin hydrobromide dissolved in water basically does not change color under light conditions for 7 days.

[0024] Embodiment 3: antibacterial agent preparation for injection

[0025] Take an appropriate amount of quinolone gatifloxacin hydrobromide, and operate according to the preparation process procedures of injection, powder injection, and freeze-dried powder injection. During the preparation process, an appropriate amount of ph...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention discloses Gatifloxacin hydrobromate as one kind of quinolone compound and its chemical structural expression, preparation and application. The preparation process adopts Gatifloxacin as main material, and includes reaction with hydrobromic acid in organic solvent or water at 40-50 deg.c for 1-5 hr to produce salt, and subsequent crystallization to obtain Gatifloxacin hydrobromate product. The compound has high water solubility, high stability and less irritation, and its Gatifloxacin component produces antibacterial effect in human body to treat various infectious diseases.

Description

technical field [0001] The invention relates to a quinolone compound, gatifloxacin hydrobromide, namely: hydrobromic acid, 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piper Azinyl)-1,4-trihydro-4-oxidation-3-quinolinic acid, a preparation method of the compound, and an application of the compound as an antibacterial agent. Background technique [0002] Gatifloxacin (Gatifloxacin) is the fourth generation of fluoroquinolone antibacterial drugs, the drug has excellent broad-spectrum activity, not only maintains the strong activity of ciprofloxacin, ofloxacin, levofloxacin, etc. against Gram-negative bacteria Advantages, while overcoming their shortcomings of Gram-positive bacteria (especially Streptococcus pneumoniae), anaerobic bacteria, mycoplasma, chlamydia, mycobacteria, etc. are not active, and these pathogens also have better activity. In addition, gatifloxacin is rapidly absorbed orally, widely distributed in tissues, has a low serum protein binding rate, and has a ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/496A61P31/04C07D401/04
Inventor 汤小东汤旭东
Owner 海南康福中正发展有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap